{"id":"https://openalex.org/W4362485655","doi":"https://doi.org/10.1158/1541-7786.22511161","title":"Supplementary Methods, Figure Legends from Beneficial Effects of RAF Inhibitor in Mutant BRAF Splice Variant\u2013Expressing Melanoma","display_name":"Supplementary Methods, Figure Legends from Beneficial Effects of RAF Inhibitor in Mutant BRAF Splice Variant\u2013Expressing Melanoma","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362485655","doi":"https://doi.org/10.1158/1541-7786.22511161"},"language":"en","primary_location":{"id":"doi:10.1158/1541-7786.22511161","doi":"https://doi.org/10.1158/1541-7786.22511161","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1541-7786.22511161","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_Figure_Legends_from_Beneficial_Effects_of_RAF_Inhibitor_in_Mutant_BRAF_Splice_Variant_Expressing_Melanoma/22511161/1/files/39973123.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_Figure_Legends_from_Beneficial_Effects_of_RAF_Inhibitor_in_Mutant_BRAF_Splice_Variant_Expressing_Melanoma/22511161/1/files/39973123.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050694888","display_name":"Edward J. Hartsough","orcid":"https://orcid.org/0000-0002-5109-3978","observed_orcids":["https://orcid.org/0000-0002-5109-3978"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edward J. Hartsough","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033787308","display_name":"Kevin J. Basile","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin J. Basile","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5062746446","display_name":"Andrew E. Aplin","orcid":"https://orcid.org/0000-0002-2734-3244","observed_orcids":["https://orcid.org/0000-0002-2734-3244"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew E. Aplin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11173","display_name":"Neurofibromatosis and Schwannoma Cases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/raf-inhibitors","display_name":"RAF inhibitors","score":0.8109999895095825},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.7889999747276306},{"id":"https://openalex.org/keywords/braf-mutation","display_name":"BRAF mutation","score":0.7099999785423279},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.5690000057220459}],"concepts":[{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.7275601625442505},{"id":"https://openalex.org/C2780989783","wikidata":"https://www.wikidata.org/wiki/Q7578557","display_name":"splice","level":3,"score":0.7172631621360779},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.5811988711357117},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.41462618112564087},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32238245010375977},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.30302518606185913},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.20386970043182373}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1541-7786.22511161","doi":"https://doi.org/10.1158/1541-7786.22511161","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1541-7786.22511161","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_Figure_Legends_from_Beneficial_Effects_of_RAF_Inhibitor_in_Mutant_BRAF_Splice_Variant_Expressing_Melanoma/22511161/1/files/39973123.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1541-7786.22511161.v1","doi":"https://doi.org/10.1158/1541-7786.22511161.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1541-7786.22511161.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22511161","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Methods_Figure_Legends_from_Beneficial_Effects_of_RAF_Inhibitor_in_Mutant_BRAF_Splice_Variant_Expressing_Melanoma/22511161","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1541-7786.22511161","doi":"https://doi.org/10.1158/1541-7786.22511161","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1541-7786.22511161","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_Figure_Legends_from_Beneficial_Effects_of_RAF_Inhibitor_in_Mutant_BRAF_Splice_Variant_Expressing_Melanoma/22511161/1/files/39973123.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.46810001134872437,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W4362485655.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2142913791","https://openalex.org/W4392698844","https://openalex.org/W7099087579","https://openalex.org/W4362550717","https://openalex.org/W2043058822","https://openalex.org/W4361819274","https://openalex.org/W2956010168","https://openalex.org/W2033014187","https://openalex.org/W4253801673","https://openalex.org/W7097889279"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}